⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL296385 | 0.76 | — | — | |
| SCHEMBL8042061 | 0.71 | — | — | |
| SCHEMBL25375775 | 0.71 | — | — | |
| SCHEMBL194088 | 0.67 | — | — | |
| SCHEMBL126523 | 0.62 | — | — | |
| SCHEMBL7548913 | 0.60 | — | — | |
| SCHEMBL3005557 | 0.58 | — | — | |
| SCHEMBL31368697 | 0.56 | — | — | |
| SCHEMBL129122 | 0.53 | — | — | |
| SCHEMBL817379 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238440-A1 | PREPARATION METHOD FOR AND APPLICATION OF ANTIBODY CONJUGATED DRUG | HYSLINK THERAPEUTICS (CN) | 2024-07-18 | — | — | US | disclosed |
| EP-4393937-A1 | STEROID COMPOUND AND CONJUGATE THEREOF | Duality Biologics (Suzhou) Co., Ltd. (CN) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024137742-A1 | COMPOUNDS AND COMPOSITIONS AS FGFR3 DEGRADERS AND USES THEREOF | BLUEPRINT MEDICINES CORPORATION (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024130095-A1 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-06-20 | — | — | WO | disclosed |
| EP-4357348-A1 | ANTITUMOR COMPOUND AND USE THEREOF | Minghui Pharmaceutical (Hangzhou) Ltd. (CN) | 2024-04-24 | — | — | EP | disclosed |
| WO-2024073475-A1 | CEREBLON LIGANDS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024064328-A1 | COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 DEGRADERS AND USES THEREOF | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024064316-A1 | COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 INHIBITORS AND USES THEREOF | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-03-28 | — | — | WO | disclosed |
| EP-4331611-A1 | PREPARATION METHOD AND APPLICATION OF ANTIBODY DRUG CONJUGATE | Hyslink Therapeutics (CN) | 2024-03-06 | — | — | EP | disclosed |
| EP-4331612-A1 | PREPARATION METHOD FOR AND APPLICATION OF ANTIBODY CONJUGATED DRUG | Hyslink Therapeutics (CN) | 2024-03-06 | — | — | EP | disclosed |
| EP-2292589-A1 | Novel multifunctional peptidase inhibitors, especially for medical use | IMTM GmbH (DE) | 2011-03-09 | — | — | EP | disclosed |
| EP-2178527-A1 | METHOD FOR ACTIVATING REGULATORY T-CELLS | IMTM GmbH (DE) | 2010-04-28 | — | — | EP | disclosed |
| US-20090221530-A1 | Relaxase Modulators and Methods of Using Same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-09-03 | — | — | US | disclosed |
| US-20090124667-A1 | Novel Dual-Use Peptidase Inhibitors as Prodrugs for a Therapy of Inflammatory and Other Diseases | IMTM GMBH (DE) | 2009-05-14 | — | — | US | disclosed |
| WO-2009024348-A1 | METHOD FOR ACTIVATING REGULATORY T-CELLS | IMTM GMBH (DE) | 2009-02-26 | — | — | WO | disclosed |
| EP-1948627-A1 | NOVEL DUAL PEPTIDASE INHIBITORS AS PRODRUGS FOR THE THERAPY OF INFLAMMATORY AND OTHER DISORDERS | IMTM GmbH (DE) | 2008-07-30 | — | — | EP | disclosed |
| WO-2007079963-A1 | METHOD FOR PRODUCTION AND USE OF NOVEL ORGANOMETAL CATALYSTS HAVING CARBOCYCLIC CARBENES AS STABILIZING AND CONTROL LIGANDS | CATATECH GMBH (DE) | 2007-07-19 | — | — | WO | disclosed |
| WO-2007057128-A1 | NOVEL DUAL PEPTIDASE INHIBITORS AS PRODRUGS FOR THE THERAPY OF INFLAMMATORY AND OTHER DISORDERS | IMTM GMBH (DE) | 2007-05-24 | — | — | WO | disclosed |
| US-5443947-A | Heat stabilized silver chloride photographic emulsions containing thiosulfonate/sulfinate compounds | EASTMAN KODAK COMPANY (US) | 1995-08-22 | — | — | US | disclosed |
| EP-0655644-A1 | Heat stabilized silver chloride photographic emulsions containing thiosulfonate/sulfinate compounds | EASTMAN KODAK COMPANY (US) | 1995-05-31 | — | — | EP | disclosed |